A Practical Review of C-Peptide Testing in Diabetes
www.ncbi.nlm.nih.gov › pmc › articlesMay 08, 2017 · Further to this a retrospective cohort study in a single diabetes outpatient center in Sweden found that a median fasting c-peptide concentration at diagnosis was lower in patients immediately treated with insulin (0.24 nmol/l, range 0.10–1.54) compared with those managed initially with diet with or without oral therapy (0.73 nmol/l, range 0.10–4.10) . fCP of less than 0.25 nmol/l at diagnosis as an independent factor had 60% sensitivity and 96% specificity for association with insulin ...